{"count":220363,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2077","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2075","results":[{"created":"2019-12-02T10:43:59.217215+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.146","user_name":"Seb L","item_type":"entity","text":"Gene: cfap57 has been classified as Amber List (Moderate Evidence).","entity_name":"CFAP57","entity_type":"gene"},{"created":"2019-12-02T10:43:30.543784+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.145","user_name":"Seb L","item_type":"entity","text":"Marked gene: CFAP57 as ready","entity_name":"CFAP57","entity_type":"gene"},{"created":"2019-12-02T10:43:30.535740+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.145","user_name":"Seb L","item_type":"entity","text":"Gene: cfap57 has been classified as Green List (High Evidence).","entity_name":"CFAP57","entity_type":"gene"},{"created":"2019-12-02T10:42:46.006586+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.145","user_name":"Seb L","item_type":"entity","text":"reviewed gene: CFAP57: Rating: AMBER; Mode of pathogenicity: None; Publications: bioRxiv 773028, doi: https://doi.org/10.1101/773028; Phenotypes: ; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CFAP57","entity_type":"gene"},{"created":"2019-12-02T10:39:17.429088+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EXT2 as ready","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:39:17.421954+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ext2 has been classified as Green List (High Evidence).","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:39:04.663379+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EXT2 as Green List (high evidence)","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:39:04.654410+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.16","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ext2 has been classified as Green List (High Evidence).","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:38:36.520317+11:00","panel_name":"Genetic Epilepsy_AustralianGenomics_VCGS","panel_id":202,"panel_version":"0.15","user_name":"Zornitza Stark","item_type":"entity","text":"gene: EXT2 was added\ngene: EXT2 was added to Genetic Epilepsy_AustralianGenomics_VCGS. Sources: Expert Review\nMode of inheritance for gene: EXT2 was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: EXT2 were set to Seizures, scoliosis, and macrocephaly syndrome, MIM#616682\nReview for gene: EXT2 was set to GREEN\nAdded comment: Bi-alllelic missense variants cause a syndromic ID condition, seizures are a prominent feature. Note heterozygous variants (mostly causing premature termination) cause multiple exostoses. \nSources: Expert Review","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:32:38.323243+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.201","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EXT2 as ready","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:32:38.315377+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.201","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ext2 has been classified as Green List (High Evidence).","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:32:33.746261+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.201","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EXT2 were changed from  to Seizures, scoliosis, and macrocephaly syndrome, MIM#616682","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:32:15.331553+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.200","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EXT2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:31:53.178943+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EXT2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Seizures, scoliosis, and macrocephaly syndrome, MIM#616682; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EXT2","entity_type":"gene"},{"created":"2019-12-02T10:24:24.885170+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EXOSC8 as ready","entity_name":"EXOSC8","entity_type":"gene"},{"created":"2019-12-02T10:24:24.877481+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: exosc8 has been classified as Green List (High Evidence).","entity_name":"EXOSC8","entity_type":"gene"},{"created":"2019-12-02T10:24:20.543491+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.199","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EXOSC8 were changed from  to Pontocerebellar hypoplasia, type 1C, MIM#616081","entity_name":"EXOSC8","entity_type":"gene"},{"created":"2019-12-02T10:24:09.938515+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.198","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: EXOSC8 were set to ","entity_name":"EXOSC8","entity_type":"gene"},{"created":"2019-12-02T10:23:55.314289+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.197","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EXOSC8 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EXOSC8","entity_type":"gene"},{"created":"2019-12-02T10:23:42.275169+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EXOSC8: Rating: GREEN; Mode of pathogenicity: None; Publications: 24989451, 29656927; Phenotypes: Pontocerebellar hypoplasia, type 1C, MIM#616081; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EXOSC8","entity_type":"gene"},{"created":"2019-12-02T10:03:39.267839+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.145","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EXOSC2 as ready","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T10:03:39.260558+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.145","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: exosc2 has been classified as Amber List (Moderate Evidence).","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T10:03:21.789314+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.145","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EXOSC2 were changed from  to Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, MIM# 617763","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T10:03:07.809857+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.144","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: EXOSC2 were set to ","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T10:02:48.130066+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.143","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EXOSC2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T10:02:40.467101+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EXOSC2 as Amber List (moderate evidence)","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T10:02:40.454281+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.142","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: exosc2 has been classified as Amber List (Moderate Evidence).","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T09:59:46.004643+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EXOSC2 as ready","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T09:59:45.995105+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: exosc2 has been classified as Amber List (Moderate Evidence).","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T09:59:38.435340+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EXOSC2 as Amber List (moderate evidence)","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T09:59:38.427976+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.196","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: exosc2 has been classified as Amber List (Moderate Evidence).","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T09:59:22.971850+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.195","user_name":"Zornitza Stark","item_type":"entity","text":"gene: EXOSC2 was added\ngene: EXOSC2 was added to Intellectual disability, syndromic and non-syndromic_GHQ. Sources: Expert list\nMode of inheritance for gene: EXOSC2 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: EXOSC2 were set to 26843489; 31628467\nPhenotypes for gene: EXOSC2 were set to Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, MIM# 617763\nReview for gene: EXOSC2 was set to GREEN\nAdded comment: Three individuals from two families, but founder mutation, some functional data. \nSources: Expert list","entity_name":"EXOSC2","entity_type":"gene"},{"created":"2019-12-02T09:46:59.776141+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.194","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ETFDH were changed from  to Glutaric acidemia IIC, MIM#231680","entity_name":"ETFDH","entity_type":"gene"},{"created":"2019-12-02T09:46:49.174451+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.193","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ETFDH was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ETFDH","entity_type":"gene"},{"created":"2019-12-02T09:46:35.973551+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ETFDH: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Glutaric acidemia IIC, MIM#231680; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ETFDH","entity_type":"gene"},{"created":"2019-12-02T09:43:20.625986+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ETFB as ready","entity_name":"ETFB","entity_type":"gene"},{"created":"2019-12-02T09:43:20.618262+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: etfb has been classified as Green List (High Evidence).","entity_name":"ETFB","entity_type":"gene"},{"created":"2019-12-02T09:43:17.040538+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.192","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ETFB were changed from  to Glutaric acidemia IIB, MIM#231680","entity_name":"ETFB","entity_type":"gene"},{"created":"2019-12-02T09:42:59.218127+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.191","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ETFB was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ETFB","entity_type":"gene"},{"created":"2019-12-02T09:42:45.284225+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.190","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ETFB: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Glutaric acidemia IIB, MIM#231680; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ETFB","entity_type":"gene"},{"created":"2019-12-02T09:38:08.323778+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.190","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ETFA were changed from  to Glutaric acidemia IIA, MIM#231680","entity_name":"ETFA","entity_type":"gene"},{"created":"2019-12-02T09:37:50.937036+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.189","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ETFA was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ETFA","entity_type":"gene"},{"created":"2019-12-02T09:37:35.987576+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.188","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ETFA: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Glutaric acidemia IIA, MIM#231680; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ETFA","entity_type":"gene"},{"created":"2019-12-02T09:08:54.177380+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.188","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EVC2 as ready","entity_name":"EVC2","entity_type":"gene"},{"created":"2019-12-02T09:08:54.170334+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.188","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: evc2 has been classified as Red List (Low Evidence).","entity_name":"EVC2","entity_type":"gene"},{"created":"2019-12-02T09:08:49.825604+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.188","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EVC2 were changed from  to Ellis-van Creveld syndrome, MIM#225500","entity_name":"EVC2","entity_type":"gene"},{"created":"2019-12-02T09:08:38.619528+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.187","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EVC2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EVC2","entity_type":"gene"},{"created":"2019-12-02T09:08:30.370559+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.186","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EVC2 as Red List (low evidence)","entity_name":"EVC2","entity_type":"gene"},{"created":"2019-12-02T09:08:30.363444+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.186","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: evc2 has been classified as Red List (Low Evidence).","entity_name":"EVC2","entity_type":"gene"},{"created":"2019-12-02T09:08:14.011877+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EVC2: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Ellis-van Creveld syndrome, MIM#225500; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EVC2","entity_type":"gene"},{"created":"2019-12-02T09:07:09.624788+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: EVC as ready","entity_name":"EVC","entity_type":"gene"},{"created":"2019-12-02T09:07:09.616983+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: evc has been classified as Red List (Low Evidence).","entity_name":"EVC","entity_type":"gene"},{"created":"2019-12-02T09:07:02.361460+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.185","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: EVC were changed from  to Ellis-van Creveld syndrome, MIM#225500","entity_name":"EVC","entity_type":"gene"},{"created":"2019-12-02T09:06:49.108206+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.184","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: EVC was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"EVC","entity_type":"gene"},{"created":"2019-12-02T09:06:43.126218+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.183","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: EVC as Red List (low evidence)","entity_name":"EVC","entity_type":"gene"},{"created":"2019-12-02T09:06:43.118626+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.183","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: evc has been classified as Red List (Low Evidence).","entity_name":"EVC","entity_type":"gene"},{"created":"2019-12-02T09:06:30.788206+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: EVC: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Ellis-van Creveld syndrome, MIM#225500; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"EVC","entity_type":"gene"},{"created":"2019-12-02T06:46:47.543290+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ERMARD as ready","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:46:47.536103+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:46:42.859190+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.182","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ERMARD were changed from  to Periventricular nodular heterotopia 6, MIM#615544","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:46:31.876231+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.181","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ERMARD were set to ","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:46:21.305074+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.180","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ERMARD was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:46:14.324953+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.179","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ERMARD as Red List (low evidence)","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:46:14.316974+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.179","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:45:57.190536+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ERMARD as ready","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:45:57.187197+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"Added comment: Comment when marking as ready: Single affected individual described in heterozygous missense in this gene; rest of evidence is based on cytogenetic data.","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:45:57.168006+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:45:49.756337+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.140","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ERMARD were changed from  to Periventricular nodular heterotopia 6, MIM#615544","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:45:36.924698+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.139","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ERMARD were set to ","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:45:21.932930+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.138","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ERMARD was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:44:52.892422+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.137","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ERMARD as Red List (low evidence)","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:44:52.883131+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.137","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:44:28.313275+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.136","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ERMARD: Rating: RED; Mode of pathogenicity: None; Publications: 24056535, 27087860; Phenotypes: Periventricular nodular heterotopia 6, MIM#615544; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:43:46.615497+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ERMARD as ready","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:43:46.608387+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:43:41.149087+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.27","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ERMARD were changed from  to Periventricular nodular heterotopia 6, MIM#615544","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:43:20.301779+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.26","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ERMARD were set to ","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:42:58.149563+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.25","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ERMARD was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:42:28.346894+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ERMARD as Red List (low evidence)","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:42:28.339306+11:00","panel_name":"Callosome_VCGS","panel_id":205,"panel_version":"0.24","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:40:04.822930+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ERMARD as ready","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:40:04.814289+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:40:01.397370+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ERMARD were changed from  to Periventricular nodular heterotopia 6, MIM#615544","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:39:43.367027+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ERMARD as Red List (low evidence)","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:39:43.346845+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:39:25.415468+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ERMARD were set to ","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:39:07.758774+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ERMARD was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:38:49.696597+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ERMARD as Red List (low evidence)","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:38:49.544704+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ermard has been classified as Red List (Low Evidence).","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:38:22.022643+11:00","panel_name":"Periventricular grey matter heterotopia_AustralianGenomics_VCGS","panel_id":19,"panel_version":"0.1","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ERMARD: Rating: RED; Mode of pathogenicity: None; Publications: 24056535, 27087860; Phenotypes: Periventricular nodular heterotopia 6, MIM#615544; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:35:55.955423+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.178","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ERMARD: Rating: RED; Mode of pathogenicity: None; Publications: 24056535, 27087860; Phenotypes: Periventricular nodular heterotopia 6, MIM#615544; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ERMARD","entity_type":"gene"},{"created":"2019-12-02T06:27:58.701491+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.178","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ERLIN2 were changed from  to Spastic paraplegia 18, autosomal recessive, MIM#611225","entity_name":"ERLIN2","entity_type":"gene"},{"created":"2019-12-02T06:27:45.836456+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.177","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ERLIN2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ERLIN2","entity_type":"gene"},{"created":"2019-12-02T06:27:32.327855+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.176","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ERLIN2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Spastic paraplegia 18, autosomal recessive, MIM#611225; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ERLIN2","entity_type":"gene"},{"created":"2019-12-02T06:24:33.778930+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.176","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ERF as ready","entity_name":"ERF","entity_type":"gene"},{"created":"2019-12-02T06:24:33.766305+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.176","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: erf has been classified as Red List (Low Evidence).","entity_name":"ERF","entity_type":"gene"},{"created":"2019-12-02T06:24:28.257993+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.176","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ERF were changed from  to Chitayat syndrome, MIM#617180; Craniosynostosis 4, MIM#600775","entity_name":"ERF","entity_type":"gene"},{"created":"2019-12-02T06:24:15.185896+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.175","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ERF was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ERF","entity_type":"gene"},{"created":"2019-12-02T06:24:03.982263+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.174","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ERF as Red List (low evidence)","entity_name":"ERF","entity_type":"gene"},{"created":"2019-12-02T06:24:03.971902+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.174","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: erf has been classified as Red List (Low Evidence).","entity_name":"ERF","entity_type":"gene"}]}